Researchers at the University of Western Ontario say they’re confident their HIV vaccine is only months away from being approved for human trials.
According to a report by the National Post, lead researcher Dr. Chil-Yong Kang said the approval from the U.S. Food and Drug Administration can come as soon as two or three months.
The vaccine [...]
Filed under: Public health | Tagged: AIDS, Innovation | Leave a Comment »
What are the real access barriers to healthcare for people in Sub-Saharan Africa? The following article from the Wall Street Journal Europe provides an interesting perspective on the healthcare challenges in Nigeria, with a focus on AIDS patients. Mr. Ayodele states that the “real causes of restricted access to to AIDS drugs are Africa’s derelict transportation [...]
Filed under: Africa, Public health, intellectual property | Tagged: access to medicines, Africa, AIDS, Counterfeit drugs, patents, patient safety | Leave a Comment »
Lower tariffs to fight AIDS
25,000 people from around the world gathered this week in Mexico City for the 17th International AIDS Conference. Thomson Ayodele’s column in yesterday’s New York Post focuses on the main challenges facing patients in developing countries: lack of healthcare infrastructure and access to safe medicines.
( August 4, 2008 ) This week, 25,000 people from around the [...]
Filed under: Commentary on news & events | Tagged: AIDS, compulsory licencing, counterfeit medicines, Innovation, patents | Leave a Comment »